Inter-laboratory study of the in vitro dendritic cell migration assay for identification of contact allergens

Toxicology in Vitro

Volumn 25, Issue 8, 2011, Pages 2124-2134

  Rees, B ^a   Spiekstra, S W ^b   Carfi, M ^c   Ouwehand, K ^b   Williams, C A ^a   Corsini, E ^c   McLeod, J D ^a   Gibbs, S ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Assay; Chemokine; Dendritic cell; In vitro; Migration; MUTZ 3; Sensitizer

Indexed keywords

ALLERGEN; HAPTEN; PHOTOSENSITIZING AGENT; RANTES; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CHEMICAL STRUCTURE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE MATURATION COCKTAIL; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LABORATORY TEST; LANGERHANS CELL; MUTZ 3; NONHUMAN; PHENOTYPE; REPRODUCIBILITY; SENSITIZATION;

ALLERGENS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CHEMOKINE CCL5; CHEMOKINE CXCL12; HAPTENS; HUMANS; LABORATORIES; LANGERHANS CELLS; REPRODUCIBILITY OF RESULTS; TECHNOLOGY TRANSFER;

EID: 82655184202     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.09.021     Document Type: Article

References (34)

1. Adler S., Basketter D.A., Creton S., et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects - 2011. Arch. Toxicol. 2011, 85:367-485.
2. Aeby P., Ashikaga T., Bessou-Touya S., Schepky A., Gerberick F., Kern P., Marrec-Fairley M., Maxwell G., Ovigne J.M., Sakaguchi H., Reisinger K., Tailhardat M., Martinozzi-Teissier S., Winkler P. Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol. In Vitro 2010, 24(6):1465-1473.
3. Aiba S., Terunuma A., Manome H., Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 1997, 27:3031-3038.
4. Ashikaga T., Yoshida Y., Hirota M., Yoneyama K., Itagaki H., Sakaguchi H., Miyazawa M., Ito Y., Suzuki H., Toyoda H. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT)I. Optimization of the h-CLAT protocol. Toxicol. In Vitro 2006, 20:767-773.
5. Avniel S., Arik Z., Maly A., Sagie A., Basst H.B., Yahana M.D., Weiss I.D., Pal B., Wald O., Ad-El D., Fujii N., Renzana-Seisdedos F., Jung S., Galun E., Gur E., Peled A. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J. Invest. Dermatol. 2006, 126:468-476.
6. Basketter D.A., Clapp C., Jefferies D., Safford B., Ryan C.A., Gerberick F., Dearman R.J., Kimber I. Predictive identification of human skin sensitization thresholds. Contact Dermatitis 2005, 53(5):260-267.
7. Basketter D.A., Kimber I. Skin Irritation, false positives and the local lymph node assay: A guidance issue?. Regulatory Toxicol. Pharmacol. 2011, 61:137-140.
8. Casati S., Aeby P., Kimber I., Maxwell G., Ovigne J.M., Roggen E., Rovida C., Tosti L., Basketter D. Selection of chemicals for the development and evaluation of in vitro methods for skin sensitisation testing. Altern. Lab. Anim. 2009, 37:305-312.
9. Corsini E., Roggen E.L. Immunotoxicology: opportunities for non-animal test development. Altern. Lab. Anim. 2009, 37:387-397.
10. dos Santos G.G., Reinders J., Ouwehand K., Rustemeyer T., Scheper R.J., Gibbs S. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol. Appl. Pharmacol. 2009, 236:372-382.
11. Gerberick G.F., Ryan C.A., Kern P.S., Schlatter H., Dearman R.J., Kimber I., Patlewicz G.Y., Basketter D.A. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 2005, 16(4):157-202.
12. Gerberick G.F., Troutman J.A., Foertsch L.M., Vassallo J.D., Quijano M., Dobson R.L., Goebel C., Lepoittevin J.P. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol. Sci. 2009, 112:164-174.
13. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 2007, 97:417-427.
14. Kimber I., Basketter D.A., Butler M., Gamer A., Garrigue J.L., Gerberick G.F., Newsome C., Steiling W., Vohr H.W. Classification of contact allergens according to potency: proposals. Food Chem. Toxicol. 2003, 41(12):1799-1809.
15. Kimber I., Hilton J., Weisenberger C. The murine local lymph node assay for identification of contact allergens: a preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis 1989, 21:215-220.
16. Larsson K., Lindstedt M., Borrebaeck C.A. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006, 117:156-166.
17. Lin C.L., Suri R.M., Rahdon R.A., Austyn J.M., Roake J.A. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 1998, 28:4114-4122.
18. Masterson A.J., Sombroek C.C., de Gruijl T.D., Graus Y.M., van der Vliet H.J., Lougheed S.M., van den Eertwegh A.J., Pinedo H.M., Scheper R.J. MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 2001, 100:701-703.
19. Maxwell G., Aeby P., Ashikaga T., Bessou-Touya S., Diembeck W., Gerberick F., Kern P., Marrec-Fairley M., Ovigne J.M., Sakaguchi H., Schroeder K., Tailhardat M., Teissier S., Winkler P. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment. ALTEX 2011, 28:50-55.
20. Mitjans M., Galbiati V., Lucchi L., Viviani B., Marinovich M., Galli C.L., Corsini E. Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro. Toxicol. In Vitro 2010, 24:1803-1809.
21. Natsch A., Emter R., Ellis G. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing. Toxicol. Sci. 2009, 107:106-121.
22. Natsch A., Caroline B., Leslie F., Frank G., Kimberly N., Allison H., Heather I., Robert L., Stefan O., Hendrik R., Andreas S., Emter R. The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories. Toxicol. In Vitro. 2011, 25:733-744.
23. Neves B.M., Cruz M.T., Francisco V., Goncalo M., Figueiredo A., Duarte C.B., Lopes M.C. Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line. Toxicol. Lett. 2008, 177:74-82.
24. Ott H., Bergstrom M.A., Heise R., Skazik C., Zwadlo-Klarwasser G., Merk H.F., Baron J.M., Karlberg A.T. Cutaneous metabolic activation of carvoxime, a self-activating, skin-sensitizing prohapten. Chem. Res. Toxicol. 2009, 22:399-405.
25. Ouwehand K., Santegoets S.J., Bruynzeel D.P., Scheper R.J., de Gruijl T.D., Gibbs S. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur. J. Immunol. 2008, 38(11):3050-3059.
26. Ouwehand K., Scheper R.J., de Gruijl T.D., Gibbs S. Epidermis-to-dermis migration of immature Langerhans cells upon topical irritant exposure is dependent on CCL2 and CCL5. Eur. J. Immunol. 2010, 40:2026-2034.
27. Ouwehand K., Spiekstra S.W., Reinders J., Scheper R.J., de Gruijl T.D., Gibbs S. Comparison of a novel CXCL12/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells. Toxicol. In Vitro 2010, 24:578-585.
28. Python F., Goebel C., Aeby P. Assessment of the U937 cell line for the detection of contact allergens. Toxicol. Appl. Pharmacol 2007, 220(2):113-124.
29. Quentmeier H., Zaborski M., Drexler H.G. The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leuk. Res. 1997, 21:343-350.
30. Roggen E., Aufderheide M., Cetin Y., Dearman R.J., Gibbs S., Hermanns I., Kimber I., Regal J.F., Rovida C., Warheit D.B., Uhlig S., Casati S. The development of novel approaches to the identification of chemical and protein respiratory allergens. Altern. Lab. Anim. 2008, 36:591-598.
31. Sakaguchi H., Ashikaga T., Miyazawa M., Yoshida Y., Ito Y., Yoneyama K., Hirota M., Itagaki H., Toyoda H., Suzuki H. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT)II. An inter-laboratory study of the h-CLAT. Toxicol. In Vitro 2006, 20:774-784.
32. Schneider K., Akkan Z. Quantitative relationship between the local lymph node assay and human skin sensitization assays. Regul. Toxicol. Pharmacol. 2004, 39(3):245-255.
33. Toebak M.J., Pohlmann P.R., Sampat-Sardjoepersad S.C., von Blomberg B.M., Bruynzeel D.P., Scheper R.J., Rustemeyer T., Gibbs S. CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol. In Vitro 2006, 20:117-124.
34. Williams E.H., Williams C.A., McLeod J.D. Identification of PDL-1 as a novel biomarker of sensitizer exposure in dendritic-like cells. Toxicol. In Vitro 2010, 24:1727-1735.